Pulmonx (LUNG) Cash from Investing Activities (QoQ) (2020 - 2025)
Pulmonx (LUNG) Cash from Investing Activities (QoQ) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.63 Bn | 194.02 Bn | 7.27 Bn |
| 2 | Stryker | 127.42 Bn | 123.95 Bn | 4.50 Bn |
| 3 | Medtronic | 118.97 Bn | 109.75 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.39 Bn | 72.85 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.97 Bn | 47.72 Bn | 1.35 Bn |
| 6 | Dexcom | 34.32 Bn | 32.37 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn |
| 10 | Pulmonx | 93.95 Mn | 24.20 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 59.22% |
| Jun 30, 2025 | -66.46% |
| Mar 31, 2025 | 15.97% |
| Dec 31, 2024 | 108.37% |
| Sep 30, 2024 | 908.50% |
| Jun 30, 2024 | 66.69% |
| Mar 31, 2024 | 9.00% |
| Dec 31, 2023 | -379.13% |
| Sep 30, 2023 | 221.40% |
| Jun 30, 2023 | -241.64% |
| Mar 31, 2023 | 178.95% |
| Dec 31, 2022 | -1,752.27% |
| Sep 30, 2022 | -97.88% |
| Jun 30, 2022 | 137.00% |
| Mar 31, 2022 | 80.70% |
| Dec 31, 2021 | -753.08% |
| Sep 30, 2021 | -187.86% |
| Jun 30, 2021 | 90.54% |
| Mar 31, 2021 | -1,708.23% |
| Dec 31, 2020 | -811.84% |